“A Novel Benzenesulfonylurea-Substituted Pyridazinone Derivative with Antidiabetic Effect as the Peroxisome Proliferator-activated Receptor (PPAR-γ) Agonist” (2025) Jurnal Kimia Valensi, 11(1), pp. 18–29. doi:10.15408/jkv.v11i1.42187.